Alkermes Plc
NASDAQ:ALKS
Alkermes Plc
Free Cash Flow
Alkermes Plc
Free Cash Flow Peer Comparison
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Alkermes Plc
NASDAQ:ALKS
|
Free Cash Flow
$394.3m
|
CAGR 3-Years
102%
|
CAGR 5-Years
40%
|
CAGR 10-Years
20%
|
|
Amarin Corporation PLC
NASDAQ:AMRN
|
Free Cash Flow
$1.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Prothena Corporation PLC
NASDAQ:PRTA
|
Free Cash Flow
-$162.4m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-59%
|
CAGR 10-Years
-33%
|
|
M
|
Mural Oncology PLC
NASDAQ:MURA
|
Free Cash Flow
-$197.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Alkermes Plc's Free Cash Flow?
Free Cash Flow
394.3m
USD
Based on the financial report for Mar 31, 2024, Alkermes Plc's Free Cash Flow amounts to 394.3m USD.
What is Alkermes Plc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
20%
The average annual Free Cash Flow growth rates for Alkermes Plc have been 102% over the past three years , 40% over the past five years , and 20% over the past ten years .